Data story  ·  ASPS 2017–2024

The Post-COVID
Body Boom

In 2020, COVID shut down elective surgery. Every mommy makeover component dropped double digits. What nobody expected: the recovery wasn't a recovery. It was an explosion.

+45%
Tummy tucks vs.
pre-COVID 2019
+66%
Breast reduction
vs. 2019
+7%
Augmentation
the laggard
762K
MM component
procedures 2024
01

The year everything
stopped

In 2020, every mommy makeover component dropped double digits. Breast augmentation took the hardest hit at −33%. The lower body lift was the sole exception, holding steady — likely because its small volume meant less disruption.

Procedure20192020COVID Drop
Breast Augmentation287,085193,073−33%
Breast Reduction46,34033,574−28%
Breast Lift110,28087,051−21%
Liposuction265,209211,067−20%
Tummy Tuck118,21097,988−17%
Lower Body Lift8,1608,433+3.3%
02

The recovery that
wasn't a recovery

What happened after 2020 was unprecedented. Volumes didn't just recover — they blew past pre-pandemic levels by enormous margins. Body restoration procedures surged. Enhancement procedures didn't.

Tummy Tuck Breast Lift Liposuction Augmentation Breast Reduction
+45%
Tummy Tuck
vs. 2019 level
171K in 2024
+66%
Breast Reduction
the biggest winner
46K → 77K
+7%
Augmentation
barely above 2019
still below 2007 peak
03

Recovery indexed:
who bounced back strongest?

Indexing each procedure to its 2019 level (= 100) reveals the divergent recovery. Breast reduction is the runaway winner at 166. Tummy tucks and breast lifts sit at 140+. Augmentation barely cleared 107.

Tummy Tuck Breast Lift Liposuction Augmentation Breast Reduction
The pattern is unmistakable: body restoration procedures surged past pre-pandemic levels by 30–66%. Enhancement procedures (augmentation) returned to baseline and stopped. This isn't a recovery — it's a permanent market expansion.
04

Why the recovery was
so uneven

Four forces converged to supercharge body procedures while leaving augmentation behind.

Growth vs. 2019 by procedure (2024)
Breast Reduction
+66%
Tummy Tuck
+45%
Breast Lift
+39%
Lower Body Lift
+34%
Liposuction
+32%
Augmentation
+7%
Remote Work Effect
A tummy tuck requires 2–4 weeks of recovery. Before 2020, that meant burning all your PTO. After 2020, millions could "work from the couch." The practical barrier evaporated. Augmentation only needs 3–5 days — it didn't benefit.
Social Media Acceleration
TikTok exploded during the pandemic. #mommymakeover became one of the platform's most popular plastic surgery hashtags — creating a massive awareness engine that didn't exist before 2020.
Pandemic Psychology
The "life is short" effect lowered decision thresholds. Pent-up demand met financial reallocation — less spending on travel and dining freed up budget for cosmetic procedures.
GLP-1 Drug Pipeline
Patients losing 30–80+ lbs on Ozempic/Wegovy became prime candidates for tummy tucks, body lifts, and liposuction. This pipeline is still in its early stages.
05

Not a bounce:
a new normal

The data from 2022, 2023, and 2024 shows remarkable stability at the new, higher levels. The growth rate has slowed, but there's no sign of regression. These aren't pent-up demand numbers that will correct — they're the new normal.

TUMMY TUCK
161,948
2022
170,110
2023
171,064
2024
BREAST LIFT
143,364
2022
153,600
2023
153,616
2024
LIPOSUCTION
325,669
2022
347,782
2023
349,728
2024
Three forces are still building: GLP-1 drugs are still ramping (patients starting in 2023–2024 won't hit the OR until 2025–2027). Millennials are still aging in (trailing edge born 1996 won't hit peak MM age until the 2030s). Remote work is structural. The post-COVID body boom was Phase 1.

Five takeaways

1
Body restoration surged. Enhancement didn't.
Tummy tucks (+45%), breast lifts (+39%), liposuction (+32%), and breast reduction (+66%) all blew past 2019 levels. Augmentation grew just 7%.
2
Remote work removed the biggest barrier.
A tummy tuck requires 2–4 weeks recovery. Working from home turned that from impossible to invisible.
3
It's not a bounce — it's a new normal.
2022, 2023, and 2024 show remarkable stability at the higher level. No regression toward pre-pandemic trends.
4
The GLP-1 pipeline is still building.
Patients starting Ozempic in 2023–2024 won't reach the OR until 2025–2027. Phase 2 may be even bigger.
5
Expect longer wait times and higher prices.
Consultation-to-surgery timelines of 3–6 months are now common. The 2023 tummy tuck fee spike (+23%) signals supply constraints meeting strong demand.